Pneumococcal disease
Conditions
Interventions
None listed
Sponsors
MSD K.K.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Current managing director of elderly care facility of the questionnaire panel 2) Managing director who has been working in the current facility for 6 months or more 3) Managing director who has given informed consent for participation in this study
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vaccination rate of pneumococcal vaccine among residents of the elderly care facilities | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Status of recommendation of pneumococcal revaccination for residents of the elderly care facilities 2) Vaccination rate of influenza vaccine (2021/2022) among residents of the elderly care facilities 3) Vaccination rate of COVID-19 vaccine among residents of the elderly care facilities 4) Awareness and willingness to recommend pneumococcal vaccine, influenza vaccine and COVID-19 vaccine among managing directors of the elderly care facilities 5) Pneumococcal vaccination plans and infectious disease prevention measures for residents of the elderly care facilities and the impact of COVID-19 on them | — |
Countries
Japan
Contacts
Public ContactAtsushi Mizukami
Mebix, Inc. Research Promotion Division and Research Planning Group
Outcome results
None listed